Jones SE - Search Results

1

Mitoxantrone, cisplatin, and methyl-glyoxal bis-guanylhydrazone chemotherapy for refractory malignant lymphoma: a Southwest Oncology Group phase II trial.

Dana B, Dahlberg S, Schnitzer B, Kjeldsberg CR, Jones SE, Carden J, Mundis R, Tranum B. Dana B, et al. Among authors: jones se. Invest New Drugs. 1989 Jul;7(2-3):247-50. doi: 10.1007/BF00170868. Invest New Drugs. 1989. PMID: 2793382 Free article.

2

Mitoxantrone in advanced breast cancer: a phase II trial of the Southwest Oncology Group.

Knight WA 3rd, Von Hoff DD, Neidhart JA, Tranum BL, Fabian C, Jones SE. Knight WA 3rd, et al. Among authors: jones se. Invest New Drugs. 1983;1(2):181-4. doi: 10.1007/BF00172078. Invest New Drugs. 1983. PMID: 6678866

3

Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

Fisher RI, Miller TP, Dana BW, Jones SE, Dahlberg S, Coltman CA Jr. Fisher RI, et al. Among authors: jones se. Semin Hematol. 1987 Apr;24(2 Suppl 1):21-5. Semin Hematol. 1987. PMID: 2438778 Clinical Trial.

4

Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

Miller TP, Dana BW, Weick JK, Jones SE, Coltman CA, Dahlberg S, Fisher RI. Miller TP, et al. Among authors: jones se. Semin Hematol. 1988 Apr;25(2 Suppl 2):17-22. Semin Hematol. 1988. PMID: 2456619

5

Salvage treatment of unfavorable non-Hodgkin's lymphoma with cisplatin, amsacrine, and mitoguazone: a Southwest Oncology Group Pilot Study.

Dana BW, Jones SE, Coltman C, Stuckey WJ. Dana BW, et al. Among authors: jones se. Cancer Treat Rep. 1986 Feb;70(2):291-2. Cancer Treat Rep. 1986. PMID: 3753898

6

Phase II trial of piperazinedione in Hodgkin's disease, non-Hodgkin's lymphoma, and multiple myeloma: a Southwest Oncology Group study.

Jones SE, Tucker WG, Haut A, Tranum BL, Vaughn C, Chase EM, Durie BG. Jones SE, et al. Cancer Treat Rep. 1977 Dec;61(9):1617-21. Cancer Treat Rep. 1977. PMID: 340032 Clinical Trial.

7

Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized study.

Fabian CJ, Mansfield CM, Dahlberg S, Jones SE, Miller TP, Van Slyck E, Grozea PN, Morrison FS, Coltman CA Jr, Fisher RI. Fabian CJ, et al. Among authors: jones se. Ann Intern Med. 1994 Jun 1;120(11):903-12. doi: 10.7326/0003-4819-120-11-199406010-00002. Ann Intern Med. 1994. PMID: 8172436 Clinical Trial.

8

Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology Group.

Knight WA 3rd, Fabian C, Costanzi JJ, Jones SE, Coltman CA Jr. Knight WA 3rd, et al. Among authors: jones se. Invest New Drugs. 1983;1(3):235-7. doi: 10.1007/BF00208895. Invest New Drugs. 1983. PMID: 6678871

9

Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancer.

Jones SE, Mennel RG, Peters GN, Westrick MA, Brooks BD, Knox SM, McGuffey P. Jones SE, et al. Invest New Drugs. 1988 Sep;6(3):195-8. doi: 10.1007/BF00175397. Invest New Drugs. 1988. PMID: 2847991

10

Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma.

Braich TA, Salmon SE, Robertone A, Alberts DS, Jones SE, Miller TP, Garewal HS. Braich TA, et al. Among authors: jones se. Invest New Drugs. 1986;4(3):269-74. doi: 10.1007/BF00179595. Invest New Drugs. 1986. PMID: 3818231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

857 results

Search Page

Filters